ADVERTISEMENT

SurgOnc Today®

SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO.

Listen to the most recent episodes below or find all of the SurgOnc Today® episodes, organized by disease site, on ExpertEd@SSO. Make sure you don’t miss an episode by subscribing on Apple Podcasts, Spotify and Stitcher

ACS Commission on Cancer Surgery Standards

 


In this episode, SSO Immediate Past President James Howe, MD, SSO Secretary Kelly Hunt, MD, and Matthew Katz, MD, discuss ACS Commission on Cancer accreditation standards 5.3 through 5.8, what these standards are, where they came from, and why they are so important to all surgeons and their patients.

Timothy Mullett, MD, Stephen Swisher, MD, and Nirmal Veeramachaneni, MD discuss the Commission on Cancer (CoC) Standard 5.8 including a review of the requirements for nodal assessment during curative operation for lung cancer and best practices to accomplish the requirement.

The 2020 Commission on Cancer (CoC) accreditation standards introduced six new operative standards pertaining to the technical aspects of cancer surgery. In this episode, SSO Colorectal Disease Site Work Group Chair, David Shibata, MD, James Fleshman, MD, and David Dietz, MD, describe Standard 5.7, Total Mesorectal Excision (TME) for Rectal Cancer and will cover the details of the standard, the key steps of TME, and its’ supporting evidence.

In this episode, Edward Levine, MD Chair of the SSO Peritoneal Surface Malignancy DSWG, is joined by Brian Badgwell, MD of MD Anderson Cancer Center and Pieter Tanis, MD, PhD of the University of Amsterdam.  They discuss whether patients at high risk of peritoneal dissemination from gastric and colon cancers should undergo HIPEC as an adjuvant therapy. 

Unplanned surgical excisions of soft tissue sarcomas (“whoops operations”) can complicate the subsequent multidisciplinary management of the primary tumor due to potential microscopic tumor seeding of prior surgical sites, violation of uninvolved anatomic compartments, and sometimes a lack of gross residual tumor on staging imaging. Valerie Grignol, MD and Kilian Salerno, MD join John M. Kane III, MD, Vice-Chair of the SSO Sarcoma Disease Site Work Group, to discuss how unplanned excisions might alter the surgical and radiation decision-making for the treatment of soft tissue sarcomas.

In part two of the HPB Incidentalomas episode, Alexander A. Parikh, MD, Vice Chair of the Hepato-Pancreato-Biliary Disease Site Work Group and disease site work group members Jin He, MD, PhD, and H.J. Kim, MD discuss the incidence, workup, treatment options, and controversies in the management of benign and indolent incidental lesions involving the duodenum and pancreas.

In this episode of SurgOnc Today®, Sean Dineen, MD, Laura Lambert, MD, and Chukwuemeka Ihemelandu, MD, discuss the state of the art management of colorectal cancer metastatic to the peritoneum including natural history and treatment options. They also preview future directions for the field.

In this episode of SurgOnc Today®, Carla Fisher, MD, Amy Degnim, MD and Faina Naklis, MD, discuss the management of high risk breast lesions including radial scars, papillomas without atypia, atypical ductal hyperplasia, atypical lobular hyperplasia and lobular carcinoma in situ.

Carla Fisher, MD, is a member of the SSO Breast DSWG and Director of Breast Surgery at Indiana University, Amy Degnim, MD, is the Joe M. and Ruth Roberts Professor of Surgery and Co-Leader of the Women’s Cancer Program at the Mayo Clinic and Faina Naklis, MD, is a surgeon at Brigham and Women’s / Dana-Farber.


In this episode of SurgOnc Today®, Vadim Gushchin, MD, Brian Badgwell, MD, and Jeremy Davis, MD discuss the role and timing of preoperative treatments before cytoreduction and HIPEC for gastric cancer. The panelists offer useful tips on surgical management of gastric cancer patients with peritoneal carcinomatoses, such as how to decide on the extent of the surgery, whether patients with CDH1 mutation should be treated differently, and others.


In this episode of SurgOnc Today®, Brian Badgwell, MD, Farshid Dayyani, MD, PhD, and Maheswari Senthil, MD, discuss the management of gastric cancer peritoneal carcinomatosis. Evaluation of response to systemic treatment, use of intraperitoneal chemotherapy and nuances of patient selection for Cytoreductive surgery are discussed.

In this episode of SurgOnc Today®, Gastrointestinal Disease Site Work Group Chair, Vance Sohn, MD, discusses PRRT with SSO President, James Howe, MD and Thomas Clancy, MD from the Gastrointestinal Disease Site Work Group. They discuss the current indications, efficacy, and what the future holds for PRRT.

In this episode, Melissa Hogg, MD, Chair of the Hepato-Pancreato-Biliary Disease Site Work Group and disease site work group members Jin He, MD, PhD, and H.J. Kim, MD, discuss the common and mostly benign imaging findings of the liver and biliary system with a focus on indications for surveillance, surgery, or additional necessary work-up.

The recently published EORTC 62092 trial (STRASS) examines abdominal recurrence in patients after surgical resection of retroperitoneal sarcomas.  This randomized study compared these recurrences in patients receiving neoadjuvant radiation versus those undergoing surgery alone.  Rebecca Gladdy MD, PhD and Ashleigh Guadagnolo, MD join moderator and SSO Sarcoma Disease Site Work Group Chair, Aimee Crago, MD, PhD, to provide insight and analysis from both surgical and radiation oncology perspectives, discussing how this practice-changing trial is altering the approach to patients with these diseases. 

In this episode of SurgOnc Today®, Kandace McGuire, MD, Chair of the SSO Breast Disease Site Work Group, moderates as Breast DSWG member Jennifer Plichta, MD, MS, presents practice changing studies from 2019.

In this episode of SurgOnc Today®, Alexander Parikh, MD, MPH, Vice Chair of the SSO Hepato-Pancreato-Biliary Disease Site Work Group moderates as Marcus Tan, MD, presents practice changing studies from 2019.

In this episode of SurgOnc Today®, Tina J. Hieken, MD, Vice Chair of the SSO Melanoma Disease Site Work Group, moderates as Melanoma DSWG members, Jessica Cintolo-Gonzalez, MD, and Kelly Olino, MD, present practice changing studies from 2019.

In this episode of SurgOnc Today®, Anthony Yang, MD, MS, Chair, and Carmen Solorzano, MD, Vice-Chair of the SSO Endocrine Disease Site Work Group, moderate as Linwah Yip, MD, from the Endocrine DSWG presents the following practice changing studies in endocrine surgical oncology from 2019.

In this episode of SurgOnc Today®, Lesly Dossett, MD, University of Michigan Hospital and Health Systems, and Member of the SSO Quality Committee interviews Daniel Boffa, MD from Yale University about hospital network affiliations and how they offer great potential for access to the right specialist at the right time.

“Part 1: Opioid Optimization in Surgical Oncology: Innovations in the Outpatient and Inpatient Settings”

In this episode of SurgOnc Today®, Vance Sohn, MD and his guests Sarah DeSnyder, MD and Ching-Wei Tzeng, MD from the MD Anderson Cancer Center as they discuss the important role that surgical oncologists play in post-operative opioid optimization. Learn about innovative ways being implemented in the outpatient and inpatient settings that are leading to safer, patient-centered, post-operative pain management.

Listen here.

“Part 2: Opioid Optimization in Surgical Oncology: Lessons Learned, Tips and Tricks, and Advancing Post-Operative Care”

Join moderator Vance Sohn, MD and his guests Sarah DeSnyder, MD and Ching-Wei Tzeng, MD from the MD Anderson Cancer Center as they resume their conversation on opioid optimization. These experts will discuss lessons learned in advancing post-operative pain management as well as practical tips on how to implement optimization pathways. Listen here.

In this episode of SurgOnc Today®, SSO Secretary, Kelly Hunt, MD interviews Mehra Golshan, MD, and Eleftherios (Terry) Mamounas, MD, about their involvement with the manuscript, “COVID-19 Pandemic Breast Cancer Consortium’s Considerations for Re-Entry.” Dr. Golshan and Dr. Mamounas were appointed as SSO representatives to a consortium consisting of experts from The American Society of Breast Surgeons, the National Accreditation Program for Breast Centers, the National Comprehensive Cancer Network, the American College of Surgeons Commission on Cancer, the American College of Radiology and the American Society of Clinical Oncology.

In this episode of SurgOnc Today®, SSO President, James Howe, MD, interviews George Chang, MD, MD Anderson Cancer Center, about his experience being diagnosed with and recovering from COVID-19. Dr. Howe and Dr. Chang discussed symptoms, testing, hospitalization, returning to work and Dr. Chang’s experience donating his plasma to help give others passive immunity.

“The choice of neoadjuvant therapy for hormone receptor positive breast cancer”

In this episode of SurgOnc Today®, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma.

“Axillary management after neoadjuvant therapy in hormone receptor positive breast cancer”

In this episode of SurgOnc Today®, Armando Giuliano, MD, Tari King, MD and Melissa Pilewskie, MD, discuss the management of the axilla after preoperative systemic therapy. Evaluation of the axilla pre- and post chemotherapy along with surgical management is discussed in a case with a 3 cm, poorly differentiated invasive ductal carcinoma.

Navigate
Scroll to Top